drugset / Trial / NCT02933866

Phase III Clinical Study in Patients With Mild to Severe Scalp Psoriasis

NCT02933866 ↗

Phase 3 Completed 371 enrolled Sun Pharmaceutical Industries, Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A Randomized, Double-Blind, Vehicle-Controlled, Parallel-Design, Multiple-Site, Phase III Clinical Study to Evaluate the Efficacy and Safety of DSXS topical product in Patients with Mild to Severe Scalp Psoriasis

Timeline

Start
2016-03-11
Primary completion
2016-11-16
Completion
2017-09-29

Outcome

Missed primary endpoint

registry analysis (superiority test); DSXS Topical vs Vehicle Topical; p = 0.2961; Cochran-Mantel-Haenszel NCT02933866 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject DSXS topical Unknown — Topical

Indications